Patients The strategic opportunity: Owning the behaviour layer Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.
Sales & Marketing Pharma is marketing to the wrong mind On the benefits of instinctive marketing, over either rational or emotional.
R&D Results, reality, and recalibration: Unpacking AI hype at SC... SCOPE 2026 was dominated by one big topic: AI. You couldn’t walk five steps without hearing about something that AI was going to fix.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Digital Six ways the NHS can become the UK’s greatest testbed for te... There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.
Sales & Marketing The Omni Advantage: A concise roadmap for change, for the pe... The book launch for pharma industry veteran and award-winning businesswoman Merhnaz Campbell’s The Omni Advantage: Accelerating the Behavioural Change with Omnichannel in Pharma Sales E
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
